Concepedia

Andrew S. R. Jennings

AS

Statistics

Publications

5

Citations

116

H-Index

5

Active since

2006

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Andrew S. R. Jennings is an author at MSD (UK) Limited (United Kingdom) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2006–2010

5

Publications

5

The synthesis and preclinical evaluation in rhesus monkey of [<sup>18</sup>F]MK‐6577 and [<sup>11</sup>C]CMPyPB glycine transporter 1 positron emission tomography radiotracers

Terence G. Hamill, Waisi Eng, Andrew S. R. Jennings et al. · Synapse · 2010 · 33 citations

, , +16

A Pyridazine Series of α2/α3 Subtype Selective GABA<sub>A</sub> Agonists for the Treatment of Anxiety

Richard T. Lewis, Wesley Blackaby, Timothy J. Blackburn et al. · Journal of Medicinal Chemistry · 2006 · 30 citations · Full text

, , +17

Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1

Wesley Blackaby, Richard T. Lewis, Joanne L. Thomson et al. · ACS Medicinal Chemistry Letters · 2010 · 22 citations · Full text

, , +4

Imidazo[1,2-b][1,2,4]triazines as α2/α3 subtype selective GABAA agonists for the treatment of anxiety

Andrew S. R. Jennings, Richard T. Lewis, Michael G. N. Russell et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 18 citations · Full text

, , +12

Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors

Joanne L. Thomson, Wesley Blackaby, Andrew S. R. Jennings et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 13 citations · Full text

, , +7

1–5 of 5